IMS Health Issued the Following Statement Regarding Its Pending Acquisition of SDI
PLYMOUTH MEETING, Pa., Jan. 14, 2011-IMS Health announced today that it has signed a definitive agreement to acquire SDI, a privately held healthcare market insights and analytics firm serving the U.S. market. Terms of the transaction were not disclosed. The agreement is subject to pre-merger notification requirements of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, which will be filed shortly.
The acquisition will enable more robust patient and specialty analytics, and will give IMS the ability to provide a broader set of stakeholders with clinically-rich insights from all healthcare channels, including hospitals, providers and pharmacies. The addition of SDI’s complementary information assets and capabilities positions IMS to improve existing offerings, fuel new investments and deliver greater innovation and value to a healthcare industry that is seeking to drive increased efficiencies as a result of significant, ongoing pressure to reduce costs and expand patient access.
Operating in more than 100 countries, IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. With more than 55 years of industry experience, IMS Health offers leading-edge market intelligence products and services that are integral to clients’ day-to-day
operations, including product and portfolio management
capabilities; commercial effectiveness innovations; managed care
and consumer health offerings; and consulting and services
solutions that improve productivity and the delivery of quality
healthcare worldwide. Additional information is available at
Contact: Gary Gatyas
Posted: January 2011